Stockscreener 앱 받기
67.10
0.53%
-0.36
시간 외 거래:
67.10
Cvs Health Corp 주식(CVS)의 최신 뉴스
CVS Health Corporation (CVS): Among the Best Performing Large Cap Stocks So Far in 2025 - Insider Monkey
RBC Capital Raises Price Target for CVS Health to $81 | CVS Stock News - GuruFocus
RBC Capital Boosts Price Target for CVS to $81 Following Q1 Results | CVS Stock News - GuruFocus
CVS Health (CVS) Price Target Boosted by Analyst Following Positive Outlook | CVS Stock News - GuruFocus
Comerica Bank Reduces Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS) Embarks on Strategic Shift Amidst Health Sector Challenges - GuruFocus
2 Healthcare Stocks to Research Further and 1 to Be Wary Of - The Globe and Mail
Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter - Investing.com India
One68 Global Capital LLC Acquires Shares of 80,597 CVS Health Co. (NYSE:CVS) - MarketBeat
8 Knots Management LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) The Best Stock To Buy and Hold For 10 Years? - Insider Monkey
CVS Health (CVS) Exceeds Earnings Expectations, Analysts Maintain Revenue Forecasts - GuruFocus
CVS Health rides improving Medicare business to better-than-expected first quarter - LancasterOnline
CVS Health (CVS) Exceeds Q1 Expectations with Revenue and EPS Gains - GuruFocus
12 Best Stocks to Buy and Hold For 10 Years - Insider Monkey
CVS Health Corporation (NYSE:CVS) Q1 2025 Earnings Call Transcript - Insider Monkey
Whitebox Advisors LLC Acquires New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
Freestone Grove Partners LP Buys Shares of 806,575 CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Rides Improving Medicare Business In First Quarter - Post Journal
UBS Raises Price Target for CVS Health (CVS) to $71 | CVS Stock News - GuruFocus
CVS Health Stock Price | CVS Stock Quote, News, and History - markets.businessinsider.com
A Glimpse Into The Expert Outlook On CVS Health Through 10 Analysts - Benzinga
CVS (CVS) Shows Resilience with Solid Earnings Amid Healthcare Shifts - GuruFocus
CVS makes deal to make popular weight loss drug cheaper - TheStreet
CVS Health Raises Forecast After Strong Q1 Results - Finimize
Health Insurance Market Size to Lead USD 5,190 Bn by 2034 Rising chronic diseases and healthcare costs are fueling demand for coverage - GlobeNewswire Inc.
CVS Health (CVS) Target Price Raised to $82 by Barclays | CVS Stock News - GuruFocus
CVS reports strong Q1 earnings, will exit Aetna’s ACA plans - InsuranceNewsNet
Eli Lilly Tackles CVS Health's Cut In Zepbound Coverage - Finimize
CVS Decision Sparks Reaction in Market, Impact on Eli Lilly Anal - GuruFocus
CVS Health (CVS) Target Price Upped by BofA Amid Positive Outloo - GuruFocus
CVS Decision Sparks Reaction in Market, Impact on Eli Lilly Analyzed | CVS Stock News - GuruFocus
CVS Health (CVS) Target Price Upped by BofA Amid Positive Outlook | CVS Stock News - GuruFocus
CVS Health (CVS) Gains After Surpassing Earnings Estimates and S - GuruFocus
Northern Trust Corp Has $560.76 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Decoding CVS Health Corp (CVS): A Strategic SWOT Insight - GuruFocus
CVS (CVS) Faces DOJ Allegations of Discriminatory Practices - GuruFocus
CVS Health Corp (CVS) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
CVS Health Reports Strong Q1 2025 Results - TipRanks
What Are Wall Street Analysts' Target Price for CVS Health Stock? - MSN
Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge - Reuters
CVS Health’s Q1 2025 Earnings Call: Strong Results and Optimistic Outlook - TipRanks
Obesity Drug Price Wars Heating Up as CVS Picks Novo Over Lilly - Bloomberg.com
DOJ sues insurers over alleged Medicare Advantage kickbacks - Modern Healthcare
Zepbound Grows, But CVS/Novo Nordisk Deal For Wegovy Casts Shadow - insights.citeline.com
CVS Caremark to Place Wegovy as Preferred GLP-1 for Weight Loss - Managed Healthcare Executive
US accuses health insurers, brokers of Medicare Advantage kickback scheme - Reuters
CVS Health raises annual profit forecast as turnaround gathers steam - MSN
CVS Drops Lilly’s Zepbound from Preferred Coverage in Novo Win - Bloomberg.com
Oxford Asset Management LLP Raises Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge By Reuters - Investing.com
CVS Faces Legal Action Over Alleged Medicare Advantage Kickbacks | CVS Stock News - GuruFocus
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment - Benzinga
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS Health - Value The Markets
CVS raises profit forecast, to exit Obamacare market as turnaround gains steam - MSN
E Street CVS to shutter after 65 years in business - The GW Hatchet
CVS Health Earnings: Strong Start in Medicare Advantage Boosts 2025 Outlook - Morningstar
CVS Health Posts Better-Than-Expected Earnings, Joins CommScope, Microsoft, Meta, Chart Industries, And Other Big Stocks Moving Higher On Thursday - Benzinga
CVS Health Partners With Wegovy Maker Novo Nordisk, Hikes 2025 Guidance - Benzinga
0.52%
1.54%
자본화:
|
볼륨(24시간):